Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > Suspicious
View:
Post by BioTeck on May 06, 2022 11:52am

Suspicious

So the price is clearly being held at the 1.40 range. Given the conditions of the market and Sernova's history, we should have been back to the Canaccord PP price by now.  The fact we haven't makes me suspicious. Usually this means an upcoming PP but i don't think the management is even dumb enough to do that now. Then again, no one expected the Canaccord "deal" either.
Comment by BioTeck on May 09, 2022 6:00pm
So no one else here finds it unusual that the share price is obviously being held in a range? No concerns that this long awaited deal might dilute our shares? Injection of pharma capital in exchange for Sernova shares @ 1.40ish? Based on the trading, this is what I'm predicting. No such thing as a free lunch.
Comment by Sailboatdream on May 09, 2022 10:13pm
With share price targets of $3 by year end (which is in 7 months).  Dilution at $1.40 would be absolutely foolish!  
Comment by Metalsguy1 on May 09, 2022 10:35pm
Foolish is Spillups middle name.
Comment by BioTeck on May 09, 2022 10:37pm
They have done foolish things before. You think a company will give them rights to or a cell line for nothing? Vertex bought Semma cells for 1 billion. The way the share price is being held is very suspect. Unless the company is unknown or they aren't looking to acquire cells, it smells fishy to me. Just because the target is 3 doesn't mean it'll happen.
Comment by Metalsguy1 on May 10, 2022 7:41pm
Let's not forget we had a $1 price target for years. Then when we blew right past that target the analyst made sure the price got beat right back down.
Comment by Charly50 on May 11, 2022 4:50am
...and also the target price of 2.50 (Douglas Loe from Leede Jones Gable) grabbed the toilet. Nonetheless, I am looking to the future. We agree that P. Witkowski's presence at the event mentioned below will ensure quality: https://www.sernova.com/press/  
Comment by Mercuryfilling1 on May 11, 2022 10:30am
Charly: As the principal investigator, P. Witkowski's presence at the podium would be nice - but it's not a sure thing. He's a busy guy. Any one of his twelve co-authors might be presenting. Might be K. Golab for all we know. Apparently all will be revealed as we get closer to the date - but yeah, let's hope so.
Comment by Charly50 on May 11, 2022 5:13pm
thanks for this question. I have no doubts that Piotr will be present. HE WILL NOT PASS THIS OPPORTUNITY. There is also a lot at stake for him personally. He seems very determined. Check out his passionate posts on facebook, instagram and LinkedIn... I think he's a great person too.
Comment by Charly50 on May 11, 2022 5:50pm
Piotr Witkowski rospom1a4Mu3uig01: fi.  083  ·    Remember Liz? Liz struggled with diabetes most of her life. Eventually also her kidneys gave up and she needed dialysis. Instead, she received a living donor kidney transplant 5 years ago ...more  
Comment by BioTeck on May 11, 2022 8:38pm
Keep your bratwurst in your pants chuck. This article is about the Edmonton protocol and nothing to do with sernova.
Comment by Charly50 on May 12, 2022 8:45am
and the carrot continues to dangle.... there is no connection?? I have another opinion. I) Islet Transplant Into Man Using Sernova's Cell Pouch(TM) for ...https://finance.yahoo.com › news   LONDON, ONTARIO and EDMONTON, ALBERTA-- - Sernova Corp. and the ... offers substantial potential benefit over the Edmonton protocol   II)Has Sernova Found The Holy Grail Of Diabetes ...more  
Comment by BioTeck on May 12, 2022 9:27am
My point was that the article you posted before had nothing to do with sernova. They were talking about portal vein injection. You know, the same injection that is rendering sernova patients insulin free as it is rendering all patients insulin free - with or without the device.
Comment by Charly50 on May 12, 2022 10:24am
okay.... I spoke about Witkowski's passionate fight especially in the USA:    Siiehttps://www.isletsforus.org/?fbclid=IwAR0_H_8aL2_nQh2YUgBBKonU3pFV3OC12LeFlSntQsThybmXggPDfykP5AE know the problem:
Comment by Metalsguy1 on May 12, 2022 12:08pm
Fraulein no one gives two sh#tsabout your ridiculous posts. When will YOU ever have anything to say other than copying and pasting useless cr#p.
Comment by Charly50 on May 12, 2022 1:00pm
I can see neither content, nor quality in their posts. I'm sorry, poor little boy.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities